Gelteq is trading 15% down now at $0.49 after falling from the September 21 close of $0.57; the specific cause remains unclear.
- No new company-specific announcement, filing, earnings release, or credible news catalyst was identified for September 22, 2026.
- Recent investor-relations coverage lists earlier updates rather than a same-day event.
- The broader biotech sector is rising, so sector strength does not explain Gelteq’s decline.